The HCPLive Cardiology condition center page is a comprehensive resource for clinical news and insights on cardiovascular and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for heart disease and cardiovascular events, as well as associated diabetes, renal failure, and more...
October 25th 2024
New research indicates semaglutide reduced albuminuria and body weight in CKD patients without diabetes, highlighting its potential renal benefits.
Elevating Care for PAH: Applying Recommended Management Approaches to Maximize Outcomes
View More
‘REEL’ Time Patient Counseling™: Navigating the Complex Journey of Diagnosing and Managing Fabry Disease
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Transcatheter Aortic-Valve Replacement Deemed Safer than Open-Heart Surgery
April 16th 2014Researchers believe the less-invasive nature of transcatheter aortic-valve replacement systems allows patients to mobilize and recover in as little as one week, which contributes to the device's greater survival benefit compared to open-heart surgery.
New Blood Pressure Guidelines May Take Millions Off Hypertension Medications
New blood pressure treatment guidelines announced in February 2014 by the Eighth Joint National Committee (JNC 8) may result in nearly 6 million American adults no longer requiring hypertension medications.
More on the Controversies Surrounding Implementation of New Lipid Management Guidelines
April 13th 2014The ACC/AHA cholesterol guideline can be a powerful tool for making multifactorial measures of cardiovascular disease risk assessment, particularly in African American populations, but clinicians should be aware of its limitations.
Antihyperglycemic Agent Has No Cardiovascular Effect in Type 2 Diabetics
April 8th 2014Although the US Food and Drug Administration revised its approval processes for antihyperglycemic agents to include cardiovascular safety components, researchers still cannot discern whether those drugs affect cardiovascular outcomes.
New Guidance Issued for Atrial Fibrillation
The American Heart Association, American College of Cardiology, and the Heart Rhythm Society issued updated guidelines that include recommendations on new oral anticoagulants for the management of patients with atrial fibrillation.
Normalizing Blood Pressure May Prevent a Second Stroke
Although many clinicians presumed patients with poor collateral blood vessel formation near their stroke site should have their blood pressure left high to prevent a second stroke, a study published in Neurology found lowering blood pressure to normal levels reduces subsequent stroke risk more effectively.
Fish Oil Offers Cardioprotection in Post-op Atrial Fibrillation
April 4th 2014Up to 50% of patients who undergo bypass and heart valve surgeries develop postoperative atrial fibrillation, the result of which involves more postoperative complications, including stroke, longer hospital stays, and an increase in treatment costs.
Trial of Novel Heart Failure Drug Terminated Early Based on ‘Compelling Efficacy'
Citing interim results that met parameters for efficacy in reducing cardiovascular mortality, an independent group of experts has put an early stop to a late-stage study on Novartis's novel oral medication for chronic heart failure.
Heartache Over New Cholesterol Treatment Guidelines
April 2nd 2014To produce the greatest impact from the implementation of the new American College of Cardiology and American Heart Association guidelines for the treatment of hypercholesterolemia in the primary prevention of cardiovascular disease (CVD), physicians should counsel patients on the benefits and risks of medication intervention to prevent CVD, but also explain the absolute necessity of regular exercise and abstention from tobacco use.